Table V.
Five-year survival according to the cooperative expression of LAT1 and CD98.
| Variable | Five-year survival rate (%)a
|
||
|---|---|---|---|
| LAT1 with CD98-positivity | Other | p-valuea | |
| All patients | 24.1 | 43.6 | 0.0004 |
| Age | |||
| ≤65 years | 26.0 | 45.8 | 0.0269 |
| >65 years | 22.8 | 46.2 | 0.0002 |
| Gender | |||
| Male | 27.4 | 41.4 | 0.0299 |
| Female | 15.4 | 50.1 | 0.0007 |
| Pathologic stage | |||
| IIIA | 25.1 | 41.2 | 0.0043 |
| IIIB | 19.6 | 42.0 | 0.0167 |
| Histology | |||
| Adenocarcinoma | 19.4 | 39.7 | 0.0002 |
| Squamous cell carcinoma | 26.4 | 61.5 | 0.0090 |
a
Kaplan-Meier analysis;
b
log-rank test. LAT1, L-type amino acid transporter 1.